Testing effectiveness (Phase 2)Study completedNCT00494585What this trial is testingCEP-701 for PH-negative MyelofibrosisWho this might be right forLeukemiaMyelofibrosis M.D. Anderson Cancer Center 27
Very early researchStudy completedNCT01184885What this trial is testingA Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyWho this might be right forLymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more Sidney Kimmel Cancer Center at Thomas Jefferson University 7
Not applicableStudy completedNCT01017848What this trial is testingUrine pH as a Predictor of DiabetesWho this might be right forDiabetes Northwell Health 92
Testing effectiveness (Phase 2)Study completedNCT01666951What this trial is testingMulticenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney TransplantWho this might be right forRenal Failure Veloxis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT02523976What this trial is testingDasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaWho this might be right forAcute,Leukemia, Lymphoid Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773936What this trial is testingAdding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaWho this might be right forPhiladelphia Chromosome Positive Acute Lymphoblastic LeukemiaCD19+ Acute Leukemia SWOG Cancer Research Network 55
Testing effectiveness (Phase 2)UnknownNCT03961698What this trial is testingEvaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaWho this might be right forBreast CancerRenal Cell Carcinoma Infinity Pharmaceuticals, Inc. 91
Not applicableUnknownNCT01193933What this trial is testingMulticenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive TreatmentWho this might be right forPh-negative Adult Acute Lymphoblastic Leukemia National Research Center for Hematology, Russia 321
Testing effectiveness (Phase 2)Looking for participantsNCT07175038What this trial is testingROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)Who this might be right forPulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease AllRock Bio, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00280735What this trial is testingPh II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLCWho this might be right forLung Cancer UNC Lineberger Comprehensive Cancer Center 75
Not applicableLooking for participantsNCT03305835What this trial is testingMonogenic Kidney Stone - Genetic TestingWho this might be right forRare Kidney Stone Diseases Mayo Clinic 6,000
Not applicableUnknownNCT01325376What this trial is testingPH iWell Study to Compare an Online Interactive Technology to Self-directed Care in Overweight or Obese IndividualsWho this might be right forOverweightObesity SK Telecom Americas, Inc. 500
Large-scale testing (Phase 3)Study completedNCT01872897What this trial is testingCompound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD PatientsWho this might be right forGastroesophageal Reflux Disease Reckitt Benckiser Healthcare (UK) Limited 45
Testing effectiveness (Phase 2)Ended earlyNCT00002778What this trial is testingSargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Looking for participantsNCT06757855What this trial is testingOlverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CMLWho this might be right forCML,Blast Phase Institute of Hematology & Blood Diseases Hospital, China 29
Testing effectiveness (Phase 2)Study completedNCT01905150What this trial is testingPh 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic CancerWho this might be right forPancreatic Cancer Bruckner Oncology 34
Post-approval studies (Phase 4)Study completedNCT00980018What this trial is testingAn Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib TreatmentWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT06481228What this trial is testingEfficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALLWho this might be right forPhiladelphia Positive Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, Adult Institute of Hematology & Blood Diseases Hospital, China 82
Testing effectiveness (Phase 2)Study completedNCT00569660What this trial is testingPh II Study of Azacitidine in MyelofibrosisWho this might be right forMyelofibrosis M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01523782What this trial is testingAdministration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia ERYtech Pharma 30